Skip to main content

Advertisement

Log in

Promoting science in a pragmatic world: not (yet) time for partial opioid rotation

  • Editorial
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Abbadie C, Pasternak GW (2001) Differential in vivo internalization of MOR-1 and MOR-1C by morphine. Neuroreport 12:3069–3072

    Article  CAS  PubMed  Google Scholar 

  2. Bolan EA, Tallarida RJ, Pasternak GW (2002) Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. J Pharmacol Exp Ther 303:557–562

    Article  CAS  PubMed  Google Scholar 

  3. Caraceni A, Portenoy RK (1999) An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 82:263–274

    Article  CAS  PubMed  Google Scholar 

  4. Cherny NI (2005) How to deal with difficult pain problems. Ann Oncol 16(Suppl 2):ii79–ii87

    Article  PubMed  Google Scholar 

  5. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V, Expert Working Group of the European Association of Palliative Care Network (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19:2542–2554

    CAS  PubMed  Google Scholar 

  6. De Lima L, Sweeney C, Palmer JL, Bruera E (2004) Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother 18:59–70

    Article  Google Scholar 

  7. Fainsinger RL, Nekolaichuk CL, Lawlor PG, Neumann CM, Hanson J, Vigano A (2005) A multicenter study of the revised Edmonton staging system for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage 29:224–237

    Article  PubMed  Google Scholar 

  8. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA (2004) A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101:5135–5139

    Article  CAS  PubMed  Google Scholar 

  9. Gourlay GK (2001) Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2:165–172

    Article  CAS  PubMed  Google Scholar 

  10. Grach M, Massalha W, Pud D, Adler R, Eisenberg E (2004) Can coadministration of oxycodone and morphine produce analgesic synergy in humans? An experimental cold pain study. Br J Clin Pharmacol 58:235–242

    Article  CAS  PubMed  Google Scholar 

  11. Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587–593

    Article  CAS  PubMed  Google Scholar 

  12. Indelicato RA, Portenoy RK (2002) Opioid rotation in the management of refractory cancer pain. J Clin Oncol 20:348–352

    PubMed  Google Scholar 

  13. Lauretti GR, Oliveira GM, Pereira NL (2003) Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer 89:2027–2030

    Article  CAS  PubMed  Google Scholar 

  14. Mancini IL, Hanson J, Neumann CM, Bruera ED (2000) Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. J Palliat Med 3:49–56

    Article  CAS  PubMed  Google Scholar 

  15. Mercadante S, Villari P, Ferrera P, Casuccio A (2004) Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer 12:762–766

    Article  PubMed  Google Scholar 

  16. Miaskowski C, Dodd M, West C, Schumacher K, Paul SM, Tripathy D, Koo P (2004) Randomized clinical trial of the effectiveness of a self-care intervention to improve cancer pain management. J Clin Oncol 22:1713–1720

    Article  PubMed  Google Scholar 

  17. Morita T, Tei Y, Inoue S (2003) Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliat Med 6:557–563

    Article  PubMed  Google Scholar 

  18. Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, Neuwohner K, Schulenberg D, Radbruch L, Working Group on the Core Documentation for Palliative Care Units in Germany (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18:100–107

    Article  PubMed  Google Scholar 

  19. Ross FB, Smith MT (1997) The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 73:151–157

    Article  CAS  PubMed  Google Scholar 

  20. Strasser F (2003) Pathophysiology of anorexia/cachexia syndrome. In: Doyle D, Hanks G, Cherny N, Sir Calman K (eds). Oxford textbook of palliative medicine, 3rd edn. Oxford University Press, Oxford, pp 520–533

    Google Scholar 

  21. Strasser F, Walker P, Bruera E (2005) Palliative pain management: when both pain and suffering hurt. J Palliat Care 21(2):69–79

    Google Scholar 

  22. Wiffen PJ, Edwards JE, Barden J, McQuay HJ (2003) Oral morphine for cancer pain. Cochrane Database Syst Rev 4:CD003868

    PubMed  Google Scholar 

  23. http://www.eapcnet.org/researchNetwork/researchprojects.asp#EPOS

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Florian Strasser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strasser, F. Promoting science in a pragmatic world: not (yet) time for partial opioid rotation. Support Care Cancer 13, 765–768 (2005). https://doi.org/10.1007/s00520-005-0855-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-005-0855-y

Keywords

Navigation